Evidence map›Paper›PMID 32772006›Full record

ReviewInternational journal of health policy and management2022

Experiences of Using Cochrane Systematic Reviews by Local HTA Units.

Thomas G Poder, Marc Rhainds, Christian A Bellemare, Simon Deblois, Imane Hammana, Catherine Safianyk, Sylvie St-Jacques, Pierre Dagenais

Abstract readReview
In one paragraph

Review in International journal of health policy and management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thomas G PoderDepartment of Management, Evaluation and Health Policy, School of Public Health, University of Montreal, Montréal, QC, Canada.ORCID 0000-0001-7017-096X
Marc RhaindsHTA Unit, CHU de Québec - Université Laval, Québec, QC, Canada.ORCID 0000-0002-0333-6146
Christian A BellemareDepartment of Multidisciplinary Services, Clinical Quality Division, CIUSSS de l'Estrie-CHUS, Sherbrooke, QC, Canada.ORCID 0000-0002-4209-8152
Simon DebloisHTA Unit, CHUM, Montréal, QC, Canada.ORCID 0000-0002-0374-2486
Imane HammanaHTA Unit, CHUM, Montréal, QC, Canada.ORCID 0000-0002-7944-9868
Catherine SafianykHTA Unit, CIUSSS de la CapitaleNationale, Québec, QC, Canada.ORCID 0000-0001-6935-8746
Sylvie St-JacquesHTA Unit, CIUSSS de la CapitaleNationale, Québec, QC, Canada.ORCID 0000-0002-9215-3375
Pierre DagenaisHTA Unit, CIUSSS de l'Estrie - CHUS, Sherbrooke, QC, Canada.ORCID 0000-0001-5058-6941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the use of Cochrane systematic reviews (CSRs) by Quebec's local health technology assessment (HTA) units to promote efficiency in hospital decision-making. An online survey was conducted to examine: Characteristics of the HTA units; Knowledge about works and services from the Cochrane Collaboration; Level of satisfaction about the use of CSRs; Facilitating factors and barriers to the implementation of CSRs evidence in a local context; Suggestions to improve the use of CSRs. Data accuracy was checked by 2 independent evaluators. Ten HTA units participated. From their implementation a total of 321 HTA reports were published (49.8% included a SR). Works and services provided by the Cochrane collaboration were very well-known and HTA units were highly satisfied with CSRs (80%-100%). As regards to applicability in HTA and use of CSRs, major strengths were as follow: Useful as resource for search terms and background material; May reduce the workload (eg, brief review instead of full SR); Use to update a current review. Major weaknesses were: Limited use since no CSRs were available for many HTA projects; Difficulty to apply findings to local context; Focused only on efficacy and innocuity; Cannot be used as a substitute to a full HTA report. This study provided a unique context of assessment with a familiar group of producers, users and disseminators of CSRs in hospital setting. Since they generally used other articles from the literature or produce an original SR in complement with CSRs, this led to suggestions to improve their use of CSRs. However, the main limit for the use of CRS in local HTA will remain its lack of contextualisation. As such, this study reinforces the need to consider the notion of complementarity of experimental data informing us about causality and contextual data, allowing decision-making adapted to local issues.

Indexed as

Research ReportTechnology Assessment, BiomedicalHospitalsHumansKnowledgeResearch PersonnelCochrane Systematic ReviewHealth Technology AssessmentHospitalQuebecSystematic Review

Identifiers

PMID32772006
PMCPMC9278610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.